Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands

NAUnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

September 30, 2015

Conditions

Raynaud's PhenomenonSkin Necrosis

Interventions

DRUG

Tracleer

14 days 62,5 mg Bosentan p.o 140 days 125 mg Bosentan p.o

DRUG

Prostavasin

Prostavasin 60 µg i.v, 5 days per week for 2 weeks

Trial Locations (1)

RECRUITING

University Freiburg, Freiburg im Breisgau